Market Overview

BMO Capital Upgrades Halozyme Therapeutics, Inc. to Outperform, Raises to $12.00

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for HALO

DateFirmActionFromTo
Dec 2014MLV & Co. Initiates Coverage onBuy
Dec 2014JP MorganMaintainsOverweight
Sep 2014JefferiesMaintainsUnderperform

View More Analyst Ratings for HALO
View the Latest Analyst Ratings

Posted-In: News Upgrades Analyst Ratings

 

Related Articles (HALO)

Around the Web, We're Loving...

Get Benzinga's Newsletters